Concord Biotech Limited (BOM:543960)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Active Pharmaceutical Ingredients	9.40B
Active Pharmaceutical Ingredients Growth	13.53%
Formulations	2.60B
Formulations Growth	37.63%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
India	6.62B
India Growth	23.89%
United States	1.38B
United States Growth	27.77%
Other	4.00B
Other Growth	6.81%